{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:03:16Z","timestamp":1790532196380,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02665-w","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:16:37Z","timestamp":1741781797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integrative approach to decipher pharmacological mechanism of Cinnamomum zeylanicum essential oil in prostate cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Debajani","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheesmita","family":"Padhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Priyadarshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rout George","family":"Kerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswabhusan","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap Chandra","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghamitra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"6","key":"2665_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"2665_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.56434\/j.arch.esp.urol.20237607.62","volume":"76","author":"B Zeki","year":"2023","unstructured":"Zeki B, Cahit \u015e, Salih Y, Yavuz K, Orhun S. Metabolic syndrome is associated with prostate cancer diagnosed on biopsy but not the gleason score and the number of cancer-positive cores: a prospective controlled study. Arch Esp Urol. 2023;76(7):504\u201310.","journal-title":"Arch Esp Urol"},{"issue":"20","key":"2665_CR3","first-page":"1698","volume":"331","author":"E Harris","year":"2024","unstructured":"Harris E. Prostate cancer cases might rise to 3 million globally by 2040. JAMA. 2024;331(20):1698\u20131698.","journal-title":"JAMA"},{"key":"2665_CR4","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: Cancer Today. Lyon, France: International agency for research on cancer; https:\/\/gco.iarc.who.int\/today, Accessed July 24 2024"},{"key":"2665_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33834","author":"S He","year":"2024","unstructured":"He S, Zhang S, Sun X, Liu R, Yuan T, Chen X, Zhang X. Global research trends on the links between prostate cancer and erectile dysfunction between 2003 and 2023: a bibliometrics and visualized study. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33834.","journal-title":"Heliyon"},{"key":"2665_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.738235","author":"B Bai","year":"2021","unstructured":"Bai B, Chen Q, Jing R, He X, Wang H, Ban Y, Ye Q, Xu W, Zheng C. Molecular basis of prostate cancer and natural products as potential chemotherapeutic and chemopreventive agents. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.738235.","journal-title":"Front Pharmacol"},{"key":"2665_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.canlet.2021.07.012","volume":"520","author":"Y Gao","year":"2021","unstructured":"Gao Y, Liu Y, Liu Y, Peng Y, Yuan B, Fu Y, Qi X, Zhu Q, Cao T, Zhang S, Yin L, Li X. UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-mediated chromatin modifications. Cancer Lett. 2021;520:172\u201383.","journal-title":"Cancer Lett"},{"key":"2665_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19147","author":"M He","year":"2023","unstructured":"He M, Zhang D, Cao Y, Chi C, Zeng Z, Yang X, Yang G, Sharma K, Hu K, Enikeev M. Chimeric antigen receptor-modified T cells therapy in prostate cancer: a comprehensive review on the current state and prospects. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19147.","journal-title":"Heliyon"},{"key":"2665_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01477-w","author":"T Zhang","year":"2023","unstructured":"Zhang T, Chen X, Ju X, Yuan J, Zhou J, Zhang Z, Ju G, Xu D. PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics. Eur J Med Res. 2023. https:\/\/doi.org\/10.1186\/s40001-023-01477-w.","journal-title":"Eur J Med Res"},{"key":"2665_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33103","author":"J Li","year":"2024","unstructured":"Li J, Wang X, Xue L, He Q. Exploring the therapeutic mechanism of curcumin in prostate cancer using network pharmacology and molecular docking. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33103.","journal-title":"Heliyon"},{"key":"2665_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.semcancer.2016.06.003","volume":"40","author":"G Kallifatidis","year":"2016","unstructured":"Kallifatidis G, Hoy JJ, Lokeshwar BL. Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer. Semin Cancer Biol. 2016;40:160\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2665_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1568011023354164","volume":"2","author":"JW Ho","year":"2002","unstructured":"Ho JW, Leung Y, Chan C. Herbal medicine in the treatment of cancer. Curr Med Chem AntiCancer Agents. 2002;2(2):209\u201314.","journal-title":"Curr Med Chem AntiCancer Agents"},{"key":"2665_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31557\/APJCP.2021.22.S1.1","volume":"22","author":"AQ Khan","year":"2021","unstructured":"Khan AQ, Uddin S. Anticancer activity of natural compounds. Asian Pac J Cancer Prev. 2021;22:1\u20132.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2665_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.866154","author":"M Guo","year":"2022","unstructured":"Guo M, Jin J, Zhao D, Rong Z, Cao LQ, Li AH, Sun XY, Jia LY, Wang YD, Huang L, Li YH. Research advances on anti-cancer natural products. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.866154.","journal-title":"Front Oncol"},{"issue":"2","key":"2665_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijpps.2017v9i2.11156","volume":"9","author":"MK Balijepalli","year":"2017","unstructured":"Balijepalli MK, Buru AS, Sakirolla R, Pichika MR. Cinnamomum genus: a review on its biological activities. Int J Pharm Pharm Sci. 2017;9(2):1\u201311.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"4","key":"2665_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ppp3.10192","volume":"3","author":"L Suriyagoda","year":"2021","unstructured":"Suriyagoda L, Mohotti AJ, Vidanarachchi JK, Kodithuwakku SP, Chathurika M, Bandaranayake PC, Hetherington AM, Beneragama CK. Ceylon cinnamon\u201d: much more than just a spice. Plants People Planet. 2021;3(4):319\u201336.","journal-title":"Plants People Planet"},{"issue":"6","key":"2665_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/10408391003699550","volume":"51","author":"GK Jayaprakasha","year":"2011","unstructured":"Jayaprakasha GK, Rao LJM. Chemistry, biogenesis, and biological activities of Cinnamomumzeylanicum. Crit Rev Food Sci Nutr. 2011;51(6):547\u201362.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"2665_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.13005\/ojc\/300105","volume":"30","author":"YC Wong","year":"2014","unstructured":"Wong YC, Ahmad-Mudzaqqir MY, Wan-Nurdiyana WA. Extraction of essential oil from cinnamon (Cinnamomumzeylanicum). Orient J Chem. 2014;30(1):37\u201347.","journal-title":"Orient J Chem"},{"key":"2665_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/978-981-15-1394-7_3","volume":"2020","author":"DK Pandey","year":"2020","unstructured":"Pandey DK, Chaudhary R, Dey A, Nandy S, Banik RM, Malik T, Dwivedi P. Current knowledge of Cinnamomum species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Bioactive Natural Prod Drug Discover. 2020;2020:127\u201364.","journal-title":"Bioactive Natural Prod Drug Discover"},{"issue":"2","key":"2665_CR20","doi-asserted-by":"publisher","first-page":"e24120","DOI":"10.1016\/j.heliyon.2024.e24120","volume":"10","author":"D Mohanty","year":"2024","unstructured":"Mohanty D, Padhee S, Sahoo C, Jena S, Sahoo A, Panda PC, Nayak S, Ray A. Integrating network pharmacology and experimental verification to decipher the multitarget pharmacological mechanism of Cinnamomum zeylanicum essential oil in treating inflammation. Heliyon. 2024;10(2):e24120.","journal-title":"Heliyon"},{"issue":"11","key":"2665_CR21","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1016\/j.fct.2010.09.001","volume":"48","author":"M Unlu","year":"2010","unstructured":"Unlu M, Ergene E, Unlu GV, Zeytinoglu HS, Vural N. Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicumBlume (Lauraceae). Food Chem Toxicol. 2010;48(11):3274\u201380.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2665_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6498347","volume":"2019","author":"I Kallel","year":"2019","unstructured":"Kallel I, Hadrich B, Gargouri B, Chaabane A, Lassoued S, Gdoura R, BayoudhMessaoud AE. Optimization of cinnamon (Cinnamomum zeylanicum Blume) essential oil extraction: evaluation of antioxidant and antiproliferative effects. Evid-Based Complement Altern Med. 2019;2019(1):1\u201311.","journal-title":"Evid-Based Complement Altern Med."},{"key":"2665_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5190603","author":"B Alizadeh Behbahani","year":"2020","unstructured":"Alizadeh Behbahani B, Falah F, Lavi Arab F, Vasiee M, Tabatabaee YF. Chemical composition and antioxidant, antimicrobial, and antiproliferative activities of Cinnamomum zeylanicum bark essential oil. Evid-Based Complementary Altern Med. 2020. https:\/\/doi.org\/10.1155\/2020\/5190603.","journal-title":"Evid.-Based Complementary Altern. Med."},{"issue":"6","key":"2665_CR24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/molecules25061399","volume":"25","author":"P Kubatka","year":"2020","unstructured":"Kubatka P, Kello M, Kajo K, Samec M, Jasek K, Vybohova D, Uramova LA, Sadlonova V, Koklesova L, Murin R. Chemopreventive and therapeutic efficacy of Cinnamomum zeylanicum L. bark in experimental breast carcinoma: mechanistic in vivo and in vitro analyses. Molecules. 2020;25(6):1399.","journal-title":"Molecules"},{"key":"2665_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201900478","author":"B Najar","year":"2020","unstructured":"Najar B, Shortrede JE, Pistelli L, Buhagiar J. Chemical composition and in vitro cytotoxic screening of sixteen commercial essential oils on five cancer cell lines. Chem Biodiver. 2020. https:\/\/doi.org\/10.1002\/cbdv.201900478.","journal-title":"Chem Biodiver"},{"issue":"6","key":"2665_CR26","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.3390\/ijms24065698","volume":"24","author":"G Cappelli","year":"2023","unstructured":"Cappelli G, Giovannini D, Vilardo L, Basso A, Iannetti I, Massa M, Ruberto G, Muir R, Pastore C, D\u2019Agnano I, Mariani F. Cinnamomum zeylanicum Blume essential oil inhibits metastatic melanoma cell proliferation by triggering an incomplete tumour cell stress response. Int J Mol Sci. 2023;24(6):5698.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2665_CR27","first-page":"44","volume":"3","author":"SH El-Nabi","year":"2016","unstructured":"El-Nabi SH, El-Garawani I, El-Berry A. The apoptotic properties of Cinnamomum zeylanicum and Cymbopogon citratus on human hepatocellular carcinoma cell line (HepG2). Eur J Phar Med Res. 2016;3(9):44\u20138.","journal-title":"Eur J Phar Med Res"},{"issue":"5","key":"2665_CR28","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/life13051176","volume":"13","author":"S Caserta","year":"2023","unstructured":"Caserta S, Genovese C, Cicero N, Gangemi S, Allegra A. The anti-cancer effect of cinnamon aqueous extract: a focus on hematological malignancies. Life. 2023;13(5):1176.","journal-title":"Life"},{"issue":"3","key":"2665_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1158\/1940-6207.CAPR-22-0327","volume":"16","author":"S Gopalakrishnan","year":"2023","unstructured":"Gopalakrishnan S, Dhaware M, Sudharma AA, Mullapudi SV, Siginam SR, Gogulothu R, Mir IA, Ismail A. Chemopreventive effect of cinnamon and its bioactive compounds in a rat model of premalignant prostate carcinogenesis. Cancer Prev Res. 2023;16(3):139\u201351.","journal-title":"Cancer Prev Res"},{"issue":"5","key":"2665_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph15050572","volume":"15","author":"F Noor","year":"2022","unstructured":"Noor F, TahirulQamar M, Ashfaq UA, Albutti A, Alwashmi AS, Aljasir MA. Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals. 2022;15(5):572.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"2665_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/cimb45020086","volume":"45","author":"TH Kim","year":"2023","unstructured":"Kim TH, Yu GR, Kim H, Kim JE, Lim DW, Park WH. Network pharmacological analysis of a new herbal combination targeting hyperlipidemia and efficacy validation in vitro. Curr Issues Mol Biol. 2023;45(2):1314\u201332.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"2665_CR32","first-page":"1","volume":"19","author":"X Wa","year":"2021","unstructured":"Wa X, Wa Z-Y, Zheng JH, Shao LI. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021;19(1):1\u201311.","journal-title":"Chin J Nat Med"},{"issue":"6","key":"2665_CR33","doi-asserted-by":"publisher","first-page":"e28026","DOI":"10.1016\/j.heliyon.2024.e28026","volume":"10","author":"D Mohanty","year":"2024","unstructured":"Mohanty D, Padhee S, Priyadarshini A, Champati BB, Das PK, Jena S, Sahoo A, Panda PC, Nayak S, Ray A. Elucidating the anti-cancer potential of Cinnamomum tamala essential oil against non-small cell lung cancer: a multifaceted approach involving GC-MS profiling, network pharmacology, and morklecular dynamics simulations. Heliyon. 2024;10(6):e28026.","journal-title":"Heliyon."},{"key":"2665_CR34","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.crphar.2021.100034","volume":"2","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Hazra J, Pal K, Nelson VK, Pal M. Prostate cancer: therapeutic prospect with herbal medicine. Curr Res Pharmacol Drug Discov. 2021;2:100034.","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"2","key":"2665_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/cells9020460","volume":"9","author":"F Fontana","year":"2020","unstructured":"Fontana F, Raimondi M, Marzagalli M, Di Domizio A, Limonta P. Natural compounds in prostate cancer prevention and treatment: mechanisms of action and molecular targets. Cells. 2020;9(2):460.","journal-title":"Cells"},{"key":"2665_CR36","doi-asserted-by":"publisher","first-page":"732266","DOI":"10.3389\/fphar.2021.732266","volume":"12","author":"RK Singla","year":"2021","unstructured":"Singla RK, Sharma P, Dubey AK, Gundamaraju R, Kumar D, Kumar S, Madaan R, Shri R, Tsagkaris C, Parisi S, Joon S. Natural product-based studies for the management of castration-resistant prostate cancer: computational to clinical studies. Front Pharmacol. 2021;12:732266.","journal-title":"Front Pharmacol"},{"key":"2665_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/392674","author":"AA Carvalho","year":"2015","unstructured":"Carvalho AA, Andrade LN, de Sousa \u00c9B, de Sousa DP. Antitumor phenylpropanoids found in essential oils. Biomed Res Int. 2015. https:\/\/doi.org\/10.1155\/2015\/392674.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2665_CR38","first-page":"140","volume":"32","author":"J Peng","year":"2024","unstructured":"Peng J, Song X, Yu W, Pan Y, Zhang Y, Jian H, He B. The role and mechanism of cinnamaldehyde in cancer. J Food Drug Anal. 2024;32(2):140\u201354.","journal-title":"J Food Drug Anal"},{"issue":"2","key":"2665_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/physiologia3020013","volume":"3","author":"S Banerjee","year":"2023","unstructured":"Banerjee S, Banerjee S. Anticancer potential and molecular mechanisms of cinnamaldehyde and its congeners present in the cinnamon plant. Physiologia. 2023;3(2):173\u2013207.","journal-title":"Physiologia"},{"issue":"5","key":"2665_CR40","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ptr.5592","volume":"30","author":"SH Hong","year":"2016","unstructured":"Hong SH, Ismail IA, Kang SM, Han DC, Kwon BM. Cinnamaldehydes in cancer chemotherapy. Phytother Res. 2016;30(5):754\u201367.","journal-title":"Phytother Res"},{"key":"2665_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72797-8","author":"X Zhang","year":"2020","unstructured":"Zhang X, Shen T, Zhou X, Tang X, Gao R, Xu L, Wang L, Zhou Z, Lin J, Hu Y. Network pharmacology based virtual screening of active constituents of Prunella vulgaris L. and the molecular mechanism against breast cancer. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-72797-8.","journal-title":"Sci Rep"},{"issue":"12","key":"2665_CR42","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/nu9121367","volume":"9","author":"DP Bezerra","year":"2017","unstructured":"Bezerra DP, Milit\u00e3o GCG, De Morais MC, De Sousa DP. The dual antioxidant\/prooxidant effect of eugenol and its action in cancer development and treatment. Nutrients. 2017;9(12):1367.","journal-title":"Nutrients"},{"issue":"6","key":"2665_CR43","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.3390\/molecules17066290","volume":"17","author":"SK Jaganathan","year":"2012","unstructured":"Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules. 2012;17(6):6290\u2013304.","journal-title":"Molecules"},{"issue":"23","key":"2665_CR44","doi-asserted-by":"publisher","first-page":"7407","DOI":"10.3390\/molecules26237407","volume":"26","author":"AT Zari","year":"2021","unstructured":"Zari AT, Zari TA, Hakeem KR. Anticancer properties of eugenol: a review. Molecules. 2021;26(23):7407.","journal-title":"Molecules"},{"key":"2665_CR45","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2017.v10i3.16071","author":"F Fadilah","year":"2017","unstructured":"Fadilah F, Yanuar A, Arsianti A, Andrajati R. Phenylpropanoids eugenol scaffold and its derivatives as anticancer. Asian J Pharm Clin Res. 2017. https:\/\/doi.org\/10.22159\/ajpcr.2017.v10i3.16071.","journal-title":"Asian J Pharm Clin Res"},{"issue":"2","key":"2665_CR46","first-page":"1116","volume":"8","author":"JL Yi","year":"2015","unstructured":"Yi JL, Shi S, Shen YL, Wang L, Chen HY, Zhu J, Ding Y. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. Int J Clin Exp Pathol. 2015;8(2):1116.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"2665_CR47","first-page":"1174","volume":"23","author":"L Yin","year":"2018","unstructured":"Yin L, Sun Z, Ren Q, Su X, Zhang D. Methyl eugenol induces potent anticancer effects in RB355 human retinoblastoma cells by inducing autophagy, cell cycle arrest and inhibition of PI3K\/mTOR\/Akt signalling pathway. J BUON. 2018;23(4):1174\u20138.","journal-title":"J BUON"},{"issue":"14","key":"2665_CR48","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1016\/j.bmcl.2008.05.113","volume":"18","author":"Y Yamamoto","year":"2008","unstructured":"Yamamoto Y, Hosokawa M, Kurihara H, Maoka T, Miyashita K. Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells. Bioorg Med Chem Lett. 2008;18(14):4044\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"2665_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/A:1021692801278","volume":"8","author":"SD Catz","year":"2003","unstructured":"Catz SD, Johnson JL. BCL-2 in prostate cancer: a minireview. Apoptosis. 2003;8:29\u201337.","journal-title":"Apoptosis"},{"issue":"10","key":"2665_CR50","doi-asserted-by":"publisher","first-page":"e31204","DOI":"10.1016\/j.heliyon.2024.e31204","volume":"10","author":"B Wang","year":"2024","unstructured":"Wang B, Sun D, Li H, Chen J. A bird\u2019s eye view of the potential role of NFKBIA in pan-cancer. Heliyon. 2024;10(10):e31204.","journal-title":"Heliyon"},{"issue":"29","key":"2665_CR51","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.2174\/092986710793176339","volume":"17","author":"L Bertazza","year":"2010","unstructured":"Bertazza L, Mocellin S. The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem. 2010;17(29):3337\u201352.","journal-title":"Curr Med Chem"},{"key":"2665_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01357-7","author":"J Liang","year":"2024","unstructured":"Liang J, Zhu L, Li J, Wu K, Zhang M, Ma S, Chen X, Xia B. Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation. Discov Oncol. 2024. https:\/\/doi.org\/10.1007\/s12672-024-01357-7.","journal-title":"Discov Oncol"},{"issue":"3","key":"2665_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12079-022-00702-1","volume":"17","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Taheriazam A, Daneii P, Hassanpour A, Kakavand A, Rezaei S, Hejazi ES, Aboutalebi M, Gholamrezaie H, Saebfar H, Salimimoghadam S. Targeting PI3K\/Aktsignaling in prostate cancer therapy. J Cell Commun Signal. 2023;17(3):423\u201343.","journal-title":"J Cell Commun Signal"},{"issue":"12","key":"2665_CR54","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/bjc.2011.163","volume":"104","author":"R Mukherjee","year":"2011","unstructured":"Mukherjee R, McGuinness DH, McCall P, Underwood MA, Seywright M, Orange C, Edwards J. Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. Br J Cancer. 2011;104(12):1920\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"2665_CR55","first-page":"267","volume":"38","author":"A Goc","year":"2011","unstructured":"Goc A, Al-Husein B, Kochuparambil ST, Liu J, Heston WW, Somanath PR. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer. Int J Oncol. 2011;38(1):267\u201377.","journal-title":"Int J Oncol"},{"issue":"5","key":"2665_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/pharmaceutics16050583","volume":"16","author":"LS Pimentel","year":"2024","unstructured":"Pimentel LS, Bastos LM, Goulart LR, Ribeiro LNDM. Therapeutic effects of essential oils and their bioactive compounds on prostate cancer treatment. Pharmaceutics. 2024;16(5):583.","journal-title":"Pharmaceutics"},{"key":"2665_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/154106","author":"N Gautam","year":"2014","unstructured":"Gautam N, Mantha AK, Mittal S. Essential oils and their constituents as anticancer agents: a mechanistic view. BioMed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/154106.","journal-title":"BioMed Res Int"},{"key":"2665_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.661230","author":"AA Al-Karmalawy","year":"2021","unstructured":"Al-Karmalawy AA, Dahab MA, Metwaly AM, Elhady SS, Elkaeed EB, Eissa IH, Darwish KM. Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the h ACE2 receptor. Front Chem. 2021. https:\/\/doi.org\/10.3389\/fchem.2021.661230.","journal-title":"Front Chem"},{"key":"2665_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.730288","author":"PP Kushwaha","year":"2021","unstructured":"Kushwaha PP, Singh AK, Bansal T, Yadav A, Prajapati KS, Shuaib M, Kumar S. Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach. Front Cell Infect Microbiol. 2021. https:\/\/doi.org\/10.3389\/fcimb.2021.730288.","journal-title":"Front Cell Infect Microbiol"},{"key":"2665_CR60","doi-asserted-by":"publisher","first-page":"1352907","DOI":"10.3389\/fphar.2024.1352907","volume":"15","author":"A Khan","year":"2024","unstructured":"Khan A, Waheed Y, Kuttikrishnan S, Prabhu KS, El-Elimat T, Uddin S, Alali FQ, Agouni A. Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of neosetophomone B revealed key targets for the treatment of cancer. Front Pharmacol. 2024;15:1352907.","journal-title":"Front Pharmacol"},{"issue":"11","key":"2665_CR61","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/pathogens12111369","volume":"12","author":"M Adnan","year":"2023","unstructured":"Adnan M, Siddiqui AJ, Ashraf SA, Bardakci F, Alreshidi M, Badraoui R, Noumi E, Tepe B, Sachidanandan M, Patel M. Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the molecular targets and potential mechanism of Phoenix dactylifera (ajwa dates) against candidiasis. Pathogens. 2023;12(11):1369.","journal-title":"Pathogens"},{"issue":"37","key":"2665_CR62","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.2174\/0113816128342075240816104654","volume":"30","author":"D Mohanty","year":"2024","unstructured":"Mohanty D, Padhee S, Jena S, Sahoo A, Panda PC, Nayak S, Ray A. Exploration of pharmacological mechanism of Cinnamomum tamala essential oil in treating inflammation based on network pharmacology, molecular modelling, and experimental validation. Curr Pharm Des. 2024;30(37):2959\u201377.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"2665_CR63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/ijms19020448","volume":"19","author":"CM Pfeffer","year":"2018","unstructured":"Pfeffer CM, Singh AT. Apoptosis: a target for anticancer therapy. Int J Mol Sci. 2018;19(2):448.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2665_CR64","doi-asserted-by":"publisher","first-page":"e13807","DOI":"10.1016\/j.heliyon.2023.e13807","volume":"9","author":"A Ray","year":"2023","unstructured":"Ray A, Gadnayak A, Jena S, Sahoo A, Patnaik J, Panda PC, Nayak S. Hedychium spicatum rhizome essential oil induces apoptosis in human prostate adenocarcinoma PC-3 cells via mitochondrial stress and caspase activation. Heliyon. 2023;9(3):e13807.","journal-title":"Heliyon"},{"issue":"4","key":"2665_CR65","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.neo.7900101","volume":"2","author":"B Pucci","year":"2000","unstructured":"Pucci B, Kasten M, Giordano A. Cell cycle and apoptosis. Neoplasia. 2000;2(4):291\u20139.","journal-title":"Neoplasia"},{"key":"2665_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00629","author":"X Li","year":"2018","unstructured":"Li X, Qiu Z, Jin Q, Chen G, Guo M. Cell cycle arrest and apoptosis in HT-29 cells induced by dichloromethane fraction from Toddalia asiatica (L.) Lam. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/fphar.2018.00629.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2665_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/CAD.0000000000000430","volume":"28","author":"N Hou","year":"2017","unstructured":"Hou N, Liu N, Han J, Yan Y, Li J. Chlorogenic acid induces reactive oxygen species generation and inhibits the viability of human colon cancer cells. Anticancer Drugs. 2017;28(1):59\u201365.","journal-title":"Anticancer Drugs"},{"key":"2665_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112313","author":"T Jamali","year":"2020","unstructured":"Jamali T, Kavoosi G, Ardestani SK. In-vitro and in-vivo anti-breast cancer activity of OEO (Oliveria decumbens vent essential oil) through promoting the apoptosis and immunomodulatory effects. J Ethnopharmacol. 2020. https:\/\/doi.org\/10.1016\/j.jep.2019.112313.","journal-title":"J Ethnopharmacol"},{"key":"2665_CR69","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/CMAR.S190004","volume":"11","author":"A Ray","year":"2019","unstructured":"Ray A, Jena S, Dash B, Sahoo A, Kar B, Patnaik J, Panda PC, Nayak S, Mahapatra N. Hedychium coronarium\u00a0extract arrests cell cycle progression, induces apoptosis, and impairs migration and invasion in HeLa cervical cancer cells. Cancer Manag Res. 2019;11:483\u2013500.","journal-title":"Cancer Manag Res."}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02665-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:40:32Z","timestamp":1743554432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02665-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":69,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2665"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02665-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors of this manuscript declare that they do not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"100"}}